Convertible issuance was exceptionally robust over the quarter, and we expect a favorable issuance environment to continue.
Stories like Mendosa’s have become commonplace in the age of Ozempic. According to a 2024 Kaiser Family Foundation survey, ...
Vietnam Investment Review on MSN
Fosun Pharma Announces 2025Q3 Financial Results
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...
Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.
Among them, Lucentis® is the first anti-vascular endothelial growth factor (VEGF) drug approved for ophthalmic use in China, and has accumulated mature clinical application experience, providing ...
To help prevent oxidative stress, people need to eat foods with antioxidants and limit their exposure to oxidants, particularly free radicals ...
ZME Science on MSN
Scientists Create “Velcro Bomb” That Enables Immune Cells to Attack Solid Cancer Tumors
CAR-T cells are one of the most exciting breakthroughs in cancer treatment in recent years. Imagine a medicine, crafted from ...
Lignin as a catalyst support offers a sustainable approach to catalysis, potentially transforming industrial practices and ...
OpenAI and AMD have launched a multi-year, multi-generation partnership to deploy 6 GW of GPU compute, beginning with a 1 GW ...
JAECOO Philippines is serious about pushing the boundaries of the local SUV market. During the recently concluded global brand conference in Wuhu, China, the Philippine media contingent was among the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results